ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
Dow Jones
38.686,32
1,51%
Euro vs US Dollar
1,08565
0,00%
Bitcoin
67.748,93
0,03%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Accelrys, Inc. (MM) (ACCL)

  7. Accelrys, Inc. (MM) (ACCL) News

ACCL

Accelrys, Inc. (MM) (ACCL)

Accelrys, Inc. (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ACCL
DatumZeitQuelleÜberschriftSymbolFirma
13/02/201516h05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACCLAccelrys, Inc. (MM)
09/05/201416h07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ACCLAccelrys, Inc. (MM)
08/05/201412h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACCLAccelrys, Inc. (MM)
07/05/201421h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACCLAccelrys, Inc. (MM)
05/05/201412h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACCLAccelrys, Inc. (MM)
05/05/201412h00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h59Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h56Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h56Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h54Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h54Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h47Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201422h30Edgar (US Regulatory)(25-NSE)NASDAQ:ACCLAccelrys, Inc. (MM)
29/04/201415h46Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
28/04/201422h22Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ACCLAccelrys, Inc. (MM)
28/04/201413h28MarketwiredPierre Fabre Laboratories Selects QUMAS DocCompliance to Manage Quality Documents Across Entire OrganizationNASDAQ:ACCLAccelrys, Inc. (MM)
24/04/201423h18Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
24/04/201412h06Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ACCLAccelrys, Inc. (MM)
23/04/201417h39Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
17/04/201414h00PR Newswire (US)New ScienceCloud Mobile Applications by Accelrys Drive Collaborative Drug DiscoveryNASDAQ:ACCLAccelrys, Inc. (MM)
10/04/201414h00PR Newswire (US)Accelrys® Speeds Life Science Decisions with Next-Generation Insight®NASDAQ:ACCLAccelrys, Inc. (MM)
09/04/201417h37Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ACCLAccelrys, Inc. (MM)
09/04/201410h10Dow Jones NewsDassault Systemes Extends Offer for AccelrysNASDAQ:ACCLAccelrys, Inc. (MM)
27/03/201422h40PR Newswire (US)Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014NASDAQ:ACCLAccelrys, Inc. (MM)
27/03/201422h21PR Newswire (US)Dr. David B. Agus to Present Keynote Address on the End of Illness at Accelerate2014NASDAQ:ACCLAccelrys, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ACCL

Kürzlich von Ihnen besucht

TG
LHA
Deutsche Lufthansa
DBI
SDXP
SDAX
NYSE
DIS
Walt Disney
TG
BAS
BASF
DBI
TDXP
Tec DAX
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
FX
EURUSD
Euro vs US Dollar
FX
EURJPY
Euro vs Yen
TG
ALV
Allianz
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten